http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3843785-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d78f957fb89584142d88d427f8b107b1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| filingDate | 1972-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1974-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c1903ca44b7a90a3ecba2dadfc89f39 |
| publicationDate | 1974-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3843785-A |
| titleOfInvention | Method of treating prostatic hypertrophy with levarin |
| abstract | Orally administered compositions for treating prostatic hypertrophy are described herein, these compositions containing an effective dose of a pharmaceutical formulation comprising levarin, a polyenic macrolide. Also, the method of treating prostatic hypertrophy with such compositions, is described herein. |
| priorityDate | 1971-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.